Literature DB >> 28539764

Moyamoya disease with neuro-ophthalmic manifestations: a rare case report.

Dipankar Das1, Sanjeev Kumar Handique2, Harsha Bhattacharjee1, Sanjoy Kumar Buragohain1, Gayatri Bharali1, Akshay Chandra Deka1, Sunil Kumar Singh1.   

Abstract

Moyamoya (meaning a hazy puff of smoke) disease (MMD) is a rare, idiopathic, persistent, occlusive cerebrovascular disease involving bilateral progressive stenosis or occlusion of a terminal portion of the internal carotid artery, or a proximal portion of the anterior cerebral arteries and the middle cerebral arteries. There are irregular perforating vascular networks (moyamoya vessels), seen in the base of the brain, which produce magnetic resonance images of this 'puff of smoke' condition. Although MMD is prevalent mostly in Japan, it is also occasionally seen outside Asia. We report an interesting case of bilateral optic nerve involvement of a radiologically diagnosed case of MMD in a young lady seen in the north-east part of India.

Entities:  

Keywords:  magnetic resonance angiography; optic atrophy; stroke

Year:  2010        PMID: 28539764      PMCID: PMC5436166          DOI: 10.2147/eb.s7614

Source DB:  PubMed          Journal:  Eye Brain        ISSN: 1179-2744


  14 in total

1.  Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.

Authors:  M Fukui
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

2.  Angiogenic factors in moyamoya disease.

Authors:  T Yoshimoto; K Houkin; A Takahashi; H Abe
Journal:  Stroke       Date:  1996-12       Impact factor: 7.914

3.  Moyamoya disease--a review.

Authors:  J Suzuki; N Kodama
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

4.  Migraine with aura-like headache associated with moyamoya disease.

Authors:  Y C Park-Matsumoto; T Tazawa; J Shimizu
Journal:  Acta Neurol Scand       Date:  1999-08       Impact factor: 3.209

5.  Prothrombotic disorders in children with moyamoya syndrome.

Authors:  M Bonduel; M Hepner; G Sciuccati; A F Torres; S Tenembaum
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

6.  Familial occurrence of moyamoya disease.

Authors:  T Yamauchi; K Houkin; M Tada; H Abe
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

7.  A clinical comparison of definite moyamoya disease between South Korea and Japan.

Authors:  K Ikezaki; D H Han; T Kawano; N Kinukawa; M Fukui
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

8.  Anterior ischemic optic neuropathy in moyamoya disease: a first case report.

Authors:  C S Chen; A W Lee; S Kelman; R Wityk
Journal:  Eur J Neurol       Date:  2007-07       Impact factor: 6.089

9.  [Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease].

Authors:  Rina Nanba; Satoshi Kuroda; Makoto Takeda; Hideo Shichinohe; Naoki Nakayama; Tatsuya Ishikawa; Kiyohiro Houkin; Yoshinobu Iwasaki
Journal:  No Shinkei Geka       Date:  2003-12

10.  Clinical features of moyamoya disease in the United States.

Authors:  D Chiu; P Shedden; P Bratina; J C Grotta
Journal:  Stroke       Date:  1998-07       Impact factor: 7.914

View more
  1 in total

1.  Optic nerve sheath fenestration for visual rehabilitation in moyamoya disease.

Authors:  Atanu Barh; Bipasha Mukherjee; S Ambika
Journal:  Saudi J Ophthalmol       Date:  2021-02-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.